Additional Proxy Soliciting Materials (definitive) (defa14a)
April 26 2018 - 4:20PM
Edgar (US Regulatory)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.__)
Filed by the Registrant
|
☒
|
Filed by a Party other than the Registrant
|
☐
|
Check the appropriate box:
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2))
|
☐
|
Definitive Proxy Statement
|
☒
|
Definitive Additional Materials
|
☐
|
Soliciting Material Pursuant to § 240.14a-12
|
Atara Biotherapeutics, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
1.
|
Title of each class of securities to which transaction applies:
|
2.
|
Aggregate number of securities to which transaction applies:
|
3.
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
4.
|
Proposed maximum aggregate value of transaction:
|
☐
|
Fee paid previously with preliminary materials.
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
6.
|
Amount Previously Paid:
|
7.
|
Form, Schedule or Registration Statement No.:
|
*** Exercise Your
Right
to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on June 14, 2018
|
ATARA BIOTHERAPEUTICS, INC.
|
Meeting Information
Meeting
Type:
Annual
Meeting
For holders
as
of:
April 19,
2018
Date:
June
14,
2018
Time:
8:00 AM
PDT
Location:
2430 Conejo Spectrum St.
Thousand Oaks, CA 91320
|
|
ATARA BIOTHERAPEUTICS, INC.
611 GATEWAY BLVD., SUITE 900
SOUTH SAN FRANCISCO, CA 94080
|
You are receiving this communication because you hold shares in the company named above.
This
is
not
a
ballot.
You
cannot
use
this
notice
to
vote
these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at
www.proxyvote.com
or easily request a paper copy (see reverse
side).
We
encourage
you
to
access
and
review
all
of
the
important information contained in the proxy materials before
voting.
|
|
|
|
|
See the reverse side of this notice to obtain proxy materials and voting instructions.
|
|
|
—
Before You Vote
—
How to Access the Proxy Materials
|
Proxy Materials Available to VIEW or RECEIVE:
1.
Notice & Proxy Statement
2. Form 10-K
How to View
Online:
Have the information that is printed in the box marked by the arrow
(located on the following page) and visit:
www.proxyvote.com.
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1)
BY
INTERNET
:
www.proxyvote.com
2)
BY
TELEPHONE
:
1-800-579-1639
3)
BY
E-MAIL*
: sendmaterial@proxyvote.com
*
If
requesting
materials
by
e-mail,
please
send
a
blank
e-mail
with
the
information
that
is
printed
in
the
box
marked by the arrow
(located on the following page) in the subject line.
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 31, 2018 to facilitate timely delivery.
|
— How To Vote —
Please Choose One of the Following Voting Methods
|
Vote In Person:
Many stockholder meetings have attendance requirements including, but not limited to, the possession
of
an
attendance
ticket
issued
by
the
entity
holding
the
meeting.
Please
check
the
meeting
materials
for
any special
requirements
for
meeting
attendance.
At
the
meeting,
you
will
need
to
request
a
ballot
to
vote
these
shares.
Vote
By
Internet:
To
vote
now
by
Internet,
go
to
www.proxyvote.com.
Have
the
information
that
is
printed
in
the
box
marked
by
the
arrow
available
and
follow
the
instructions.
Vote By Mail:
You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
Voting Items
|
|
|
The
Board
of
Directors
recommends
you
vote
FOR the
following:
|
|
1.
Election of
Directors
Nominees:
01 Eric L. Dobmeier 02 William K. Heiden 03 Beth Seidenberg, M.D.
The Board of Directors recommends you vote FOR the following proposal:
2.
Ratification of the selection of Deloitte &
Touche,
LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31,
2018.
NOTE:
In their discretion, upon such other matters that may properly come before the meeting or any adjournment or adjournments thereof.
|
|
|
|
Atara Biotherapeutics (NASDAQ:ATRA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Atara Biotherapeutics (NASDAQ:ATRA)
Historical Stock Chart
From Sep 2023 to Sep 2024